Beyond Weight Loss: The Emerging Connection Between GLP-1 Agonists and Cancer Risk Reduction The landscape of metabolic medicine is shifting rapidly. While medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, …
Tag: